Ticker LaunchReverse merger · Completed · TARA
ArTara Therapeutics, Inc.
Reverse merger with Proteon Therapeutics, Inc.
ArTara Therapeutics, Inc. merged into Proteon Therapeutics, Inc., a Nasdaq-listed biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Sep 23, 2019 and closed on Jan 9, 2020. The combined company trades as ArTara Therapeutics, Inc. (TARA) on Nasdaq.
ArTara Therapeutics, later Protara Therapeutics, is a biopharmaceutical company developing treatments for lymphatic malformations and intestinal failure associated liver disease, with lead assets TARA-002 and intravenous choline chloride.
- Status
- Completed
- Private company
- ArTara Therapeutics, Inc.
- Public company
- Proteon Therapeutics, Inc.
- Public company business before
- Nasdaq-listed biopharmaceutical company
- Announced
- Sep 23, 2019
- Closed
- Jan 9, 2020
- Combined company
- ArTara Therapeutics, Inc. (TARA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Jan 10, 2020
- Closing press release / exhibit
- Announcement 8-K Sep 24, 2019
- All filings on EDGAR CIK 1359931
Other completed reverse mergers
- Loop Media, Inc.into Interlink Plus, Inc. · Feb 6, 2020
- Boomer Naturals Holdings, Inc.into Remaro Group Corp. · Jan 7, 2020
- Black Bird Potentials Inc.into Digital Development Partners, Inc. · Jan 1, 2020
- NeuroBo Pharmaceuticals, Inc.into Gemphire Therapeutics Inc. · Dec 30, 2019
- Broad Street Realty, LLC, Broad Street Ventures, LLC and affiliated Broad Street entitiesinto MedAmerica Properties Inc. · Dec 27, 2019
- Medical Practice Income, Inc. (MPI)into USA Equities Corp. · Dec 20, 2019